| Number (%) |
---|---|
Gender (n = 1829) | |
Male | 913 (49.9) |
Female | 916 (50.1) |
Age groups (n= 1829) | |
[0–2 years | 173 (9.5) |
[2–5 years | 240 (13.1) |
[5–10 years | 338 (18.5) |
[10–19 years | 328 (17.9) |
[19–50 years | 411 (22.5) |
[50–65 years | 164 (9.0) |
≥ 65 years | 175 (9.6) |
Presence of underlying comorbidities (n = 1303) | 597 (45.8) |
Number of underlying comorbidities (n= 1303) | |
None | 706 (54.2) |
One | 412 (31.6) |
Multiple comorbidities | 185 (14.2) |
Underlying comorbidities (n= 1303) | |
Cardiovascular disease | 222 (17.0) |
Chronic pulmonary disease | 54 (4.1) |
Asthma | 160 (12.3) |
Immunosuppressive state (other than malignancy) | 19 (1.5) |
Diabetes Mellitus | 96 (7.4) |
Renal disease | 52 (4.0) |
Neuromuscular disorders | 12 (0.9) |
Neurological disorders | 58 (4.5) |
Malignancy | 164 (12.6) |
Hemoglobinopathy | 30 (2.3) |
Time interval between symptom onset and speicmen collection (n = 1368) | |
0–2 days | 882 (64.5) |
3–4 days | 338 (24.7) |
> 4 days | 148 (10.8) |
Influenza Vaccine (n = 456) | 104 (22.8) |
Pregnant among childbearing age females (N = 322)a | 72 (22.4) |